Metropolitan Life Insurance Company (MetLife)’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-15,584
| Closed | -$9.06M | – | 1929 |
|
|
2024
Q1 | $9.06M | Sell |
15,584
-144
| -0.9% | -$80.8K | 0.39% | 39 |
|
|
2023
Q4 | $8.35M | Sell |
15,728
-241
| -2% | -$117K | 0.39% | 42 |
|
|
2023
Q3 | $8.08M | Sell |
15,969
-842
| -5% | -$449K | 0.42% | 36 |
|
|
2023
Q2 | $8.77M | Sell |
16,811
-732
| -4% | -$395K | 0.43% | 38 |
|
|
2023
Q1 | $10.1M | Sell |
17,543
-4,222
| -19% | -$2.38M | 0.52% | 31 |
|
|
2022
Q4 | $12M | Sell |
21,765
-732
| -3% | -$388K | 0.54% | 32 |
|
|
2022
Q3 | $11.4M | Sell |
22,497
-259
| -1% | -$145K | 0.54% | 31 |
|
|
2022
Q2 | $12.4M | Sell |
22,756
-734
| -3% | -$404K | 0.54% | 32 |
|
|
2022
Q1 | $13.9M | Sell |
23,490
-22,363
| -49% | -$12.8M | 0.49% | 33 |
|
|
2021
Q4 | $30.6M | Sell |
45,853
-1,226
| -3% | -$765K | 0.42% | 36 |
|
|
2021
Q3 | $26.9M | Sell |
47,079
-1,584
| -3% | -$869K | 0.39% | 41 |
|
|
2021
Q2 | $24.5M | Sell |
48,663
-11,217
| -19% | -$5.29M | 0.35% | 47 |
|
|
2021
Q1 | $27.3M | Sell |
59,880
-3,590
| -6% | -$1.71M | 0.41% | 40 |
|
|
2020
Q4 | $29.6M | Sell |
63,470
-2,645
| -4% | -$1.24M | 0.44% | 38 |
|
|
2020
Q3 | $29.2M | Sell |
66,115
-2,708
| -4% | -$1.12M | 0.49% | 30 |
|
|
2020
Q2 | $24.9M | Sell |
68,823
-3,132
| -4% | -$1.05M | 0.44% | 40 |
|
|
2020
Q1 | $20.4M | Sell |
71,955
-832
| -1% | -$262K | 0.42% | 42 |
|
|
2019
Q4 | $23.6M | Sell |
72,787
-183
| -0.3% | -$55.5K | 0.38% | 49 |
|
|
2019
Q3 | $21.3M | Buy |
72,970
+12,482
| +21% | +$3.57M | 0.36% | 52 |
|
|
2019
Q2 | $17.8M | Buy |
60,488
+4,373
| +8% | +$1.2M | 0.3% | 62 |
|
|
2019
Q1 | $15.4M | Sell |
56,115
-2,472
| -4% | -$615K | 0.28% | 65 |
|
|
2018
Q4 | $13.1M | Sell |
58,587
-546
| -0.9% | -$128K | 0.26% | 69 |
|
|
2018
Q3 | $14.4M | Sell |
59,133
-2,123
| -3% | -$488K | 0.24% | 72 |
|
|
2018
Q2 | $12.7M | Sell |
61,256
-8,716
| -12% | -$1.85M | 0.21% | 83 |
|
|
2018
Q1 | $14.4M | Buy |
69,972
+466
| +0.7% | +$97.8K | 0.2% | 77 |
|
|
2017
Q4 | $13.2M | Sell |
69,506
-127,927
| -65% | -$24.5M | 0.18% | 84 |
|
|
2017
Q3 | $37.4M | Buy |
197,433
+1,248
| +0.6% | +$226K | 0.23% | 75 |
|
|
2017
Q2 | $34.2M | Sell |
196,185
-4,133
| -2% | -$694K | 0.24% | 78 |
|
|
2017
Q1 | $30.8M | Sell |
200,318
-5,115
| -2% | -$782K | 0.21% | 85 |
|
|
2016
Q4 | $29M | Sell |
205,433
-4,898
| -2% | -$722K | 0.21% | 88 |
|
|
2016
Q3 | $33.5M | Sell |
210,331
-1,661
| -0.8% | -$256K | 0.25% | 76 |
|
|
2016
Q2 | $31.3M | Sell |
211,992
-1,522
| -0.7% | -$225K | 0.23% | 77 |
|
|
2016
Q1 | $30.2M | Sell |
213,514
-4,923
| -2% | -$660K | 0.23% | 79 |
|
|
2015
Q4 | $31M | Sell |
218,437
-1,831
| -0.8% | -$244K | 0.24% | 80 |
|
|
2015
Q3 | $26.9M | Sell |
220,268
-3,755
| -2% | -$489K | 0.19% | 96 |
|
|
2015
Q2 | $29.1M | Buy |
224,023
+276
| +0.1% | +$36K | 0.2% | 99 |
|
|
2015
Q1 | $30.1M | Sell |
223,747
-4,618
| -2% | -$595K | 0.22% | 94 |
|
|
2014
Q4 | $28.6M | Sell |
228,365
-716
| -0.3% | -$87.1K | 0.2% | 101 |
|
|
2014
Q3 | $27.9M | Sell |
229,081
-3,539
| -2% | -$430K | 0.2% | 102 |
|
|
2014
Q2 | $27.4M | Sell |
232,620
-422
| -0.2% | -$49.7K | 0.19% | 105 |
|
|
2014
Q1 | $28M | Buy |
233,042
+14,610
| +7% | +$1.74M | 0.19% | 100 |
|
|
2013
Q4 | $24.3M | Sell |
218,432
-5,757
| -3% | -$572K | 0.17% | 119 |
|
|
2013
Q3 | $20.7M | Sell |
224,189
-245
| -0.1% | -$22.2K | 0.16% | 129 |
|
|
2013
Q2 | $19M | Buy |
+224,434
| New | +$18.7M | 0.15% | 130 |
|
Other funds holding TMO
Metropolitan Life Insurance Company (MetLife)'s TMO Position: Q2 2024 in Review
Metropolitan Life Insurance Company (MetLife) sold out of Thermo Fisher Scientific (TMO) in Q2 2024, closing a stake of 15,584 shares — an estimated $9.06M sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in TMO in Q2 2013 and held it in 44 quarters. The position peaked at $37.4M in Q3 2017. 2,544 funds tracked by Wall St. Rank hold TMO as of Q2 2024.
- Metropolitan Life Insurance Company (MetLife) reported no remaining Thermo Fisher Scientific position as of Q2 2024 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 15,584 Thermo Fisher Scientific shares in Q2 2024, an estimated $9.06M.
- Metropolitan Life Insurance Company (MetLife) first reported a position in Thermo Fisher Scientific in Q2 2013 and held it in 44 quarters.
- Metropolitan Life Insurance Company (MetLife)'s Thermo Fisher Scientific position peaked at $37.4M in Q3 2017.
- 2,544 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2024.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.